U

Urteste SA
WSE:URT

Watchlist Manager
Urteste SA
WSE:URT
Watchlist
Price: 92 PLN 4.07% Market Closed
Market Cap: 129.7m PLN
Have any thoughts about
Urteste SA?
Write Note

Urteste SA
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Urteste SA
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
U
Urteste SA
WSE:URT
Change in Working Capital
-zł56k
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mabion SA
WSE:MAB
Change in Working Capital
zł13.4m
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Read Gene SA
WSE:RDG
Change in Working Capital
-zł348.3k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genomed SA
WSE:GEN
Change in Working Capital
zł422.4k
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bioton SA
WSE:BIO
Change in Working Capital
zł3.2m
CAGR 3-Years
N/A
CAGR 5-Years
-23%
CAGR 10-Years
N/A
S
Synthaverse SA
WSE:SVE
Change in Working Capital
-zł3.4m
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
9%
No Stocks Found

Urteste SA
Glance View

Market Cap
129.7m PLN
Industry
Biotechnology

Urteste SA specializes in the development of technology that allows the detection of cancers at early stages of their development. The company is headquartered in Gdansk, Woj. Pomorskie. The company went IPO on 2021-10-27. The firm operates in the field of medical devices for in vitro application in the field of cancer diagnostics. The technology developed by the Company involves the detection of cancer by measuring the activity of enzymes in a urine sample, using diagnostic tests that enable the detection of common cancers in their early stages. The firm offers tests for the detection of cancers such as, pancreatic cancer, prostate cancer, colorectal cancer, lung cancer, kidney cancer, liver cancer, biliary tract cancer, stomach cancer, esophageal cancer, ovarian cancer, endometrial cancer, breast cancer, leukemia, lymphoma, glioma.

URT Intrinsic Value
11.44 PLN
Overvaluation 88%
Intrinsic Value
Price
U

See Also

What is Urteste SA's Change in Working Capital?
Change in Working Capital
-56k PLN

Based on the financial report for Dec 31, 2023, Urteste SA's Change in Working Capital amounts to -56k PLN.

What is Urteste SA's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
28%

Over the last year, the Change in Working Capital growth was 70%. The average annual Change in Working Capital growth rates for Urteste SA have been 28% over the past three years .

Back to Top